CDKN1A and malignant colon neoplasm: The fact that the colon cancer cohort with high p21 expression exhibited a 23% higher 5-year survival rate compared to the low p21 expression cohort (Figure 5B) further strengthens the potential protective role of p21 protein against colon cancer.